DrLouise Durand

Louise is a postdoctoral researcher at the Royal College of Surgeons in Ireland, currently funded through a Health Research Board Secondary Data Analysis Project (HRB SDAP) award. Louise is leading analyses examining the impact of COVID-19 on opioid agonist treatment (OAT) delivery and drug-related mortality in Ireland, using routinely collected healthcare and administrative data.

Previously, Louise was funded through multiple competitive research awards, including a second HRB SDAP award (24 months), an RCPQS award (12 months), and an ILP award (36 months). Louise has extensive experience analysing large and complex healthcare datasets, particularly in the areas of drug treatment and pharmacoepidemiology. Methodological expertise includes data linkage, multivariable modelling, survival analysis, interrupted time series/ARIMA models and latent class analysis.